Profile
Caladria is a precision neuromedicine company focused on using an unbiased human data-driven approach to discover and develop novel therapeutics for neurodegenerative diseases. Co-Founder and Chief Scientific Officer Dr. Jonathan Grima is one of the world’s leading experts in the Nuclear Pore Hypothesis in neurodegeneration, for which he was awarded Forbes Top 30 under 30 in science (2019). Dr. Grima and his team are discovering new pathways and clinical assets in neurodegenerative diseases based on his discovery and previous research at Johns Hopkins University.
Dr. Grima is supported by a team of business visionaries, drug development and commercialization executives, legal experts, neuroscience and AI/ML experts and world leaders in neurodegenerative disease as scientific advisors.
Event details
Event contact
Participants
-
AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health.… -
Caladria is a precision neuromedicine company focused on using an unbiased human data-driven approach to discover and… -
Cloud DX provides award-winning Virtual Care and Remote Patient Monitoring (RPM) solutions to… -
ImmunoBiochem is an immuno-oncology biopharmaceutical company that has developed a disruptive approach to targeting… -
Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is developing… -
Mediphage is developing safe and re-dosable non-viral gene therapies based on its proprietary linear, covalently closed… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both… -
ProteinQure is a computational platform for protein drug discovery that partners with pharma to deliver experimentally… -
QurCan Therapeutics is a biotech company focused on developing next-generation RNA and chemotherapeutics… -
Quthero aims to disrupt skin care after dermatological procedures, such as laser skin resurfacing and microneedling,… -
Rapid Novor helps researchers decode immunity so they can rapidly and effortlessly develop diagnostics, therapies,… -
Spiderwort is a biomaterials company developing a platform of biocompatible, versatile, cellulose-based scaffolds for… -
Tenomix’s mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize…